Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population
- 16 September 2012
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 372 (1-2) , 27-33
Abstract
The role of DNA repair gene polymorphisms in cancer development, progression, and response to treatment has received increased attention. We conducted a prospective study to determine whether associations exist between two polymorphisms in XRCC1 and ADPRT and the outcomes of Chinese ovarian cancer patients treated with platinum-based chemotherapy. A total of 335 new cases of ovarian cancer were consecutively collected between May 2005 and May 2007. Follow-up lasted for 4 years, and the outcome measure was survival time. Individuals carrying XRCC1 194Trp/Trp had a longer survival time than did those with the Arg/Arg genotype. Similarly, those carrying XRCC1 399 Gln/Gln genotypes had 0.44-fold the risk of death than those with the Arg/Arg genotype. The combination of XRCC1 194 Trp allele and 399 Gln allele could decrease the death risk of ovarian cancer. In summary, this study is the first to evaluate the associations between polymorphisms in DNA repair gene polymorphism and the risk of ovarian cancer in Chinese population. Our study found a significant association between XRCC1 Arg399Gln and XRCC1 Arg194Trp polymorphism and the clinical outcome of ovarian cancer. Furthermore, studies with larger sample sizes are still needed to confirm these associations in Chinese population.Keywords
This publication has 41 references indexed in Scilit:
- A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based ChemotherapyJNCI: Journal of the National Cancer Institute, 2012
- XRCC1 399*Arg-related genotype and allele, but not XRCC1 His107Arg, XRCC1 Trp194Arg, KCNQ2, AT1R, and hOGG1 polymorphisms, are associated with higher susceptibility of endometriosisGynecological Endocrinology, 2011
- Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic targetNeuro-Oncology, 2011
- Poly(ADP-Ribose) Polymerase Inhibition Synergizes with 5-Fluorodeoxyuridine but not 5-Fluorouracil in Ovarian Cancer CellsCancer Research, 2011
- Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancerCarcinogenesis, 2011
- PARP Inhibitor Treatment in Ovarian and Breast CancerCurrent Problems in Cancer, 2011
- Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patientsThe Pharmacogenomics Journal, 2009
- XRCC1 interactions with base excision repair DNA intermediatesDNA Repair, 2007
- Polymorphisms of DNA repair genes are risk factors for prostate cancerEuropean Journal of Cancer, 2007
- XRCC1, XRCC3, and XPD Polymorphisms as Modifiers of the Effect of Smoking and Alcohol on Colorectal Adenoma RiskCancer Epidemiology, Biomarkers & Prevention, 2006